25 related articles for article (PubMed ID: 24621823)
1. Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
Weng TY; Wang CY; Hung YH; Chen WC; Chen YL; Lai MD
PLoS One; 2016; 11(8):e0161007. PubMed ID: 27513329
[TBL] [Abstract][Full Text] [Related]
2. Role of voltage-gated proton channel (Hv1) in cancer biology.
Alvear-Arias JJ; Pena-Pichicoi A; Carrillo C; Fernandez M; Gonzalez T; Garate JA; Gonzalez C
Front Pharmacol; 2023; 14():1175702. PubMed ID: 37153807
[TBL] [Abstract][Full Text] [Related]
3. Sedentary Behavior Research in the Chinese Population: A Systematic Scoping Review.
Bao R; Chen ST; Wang Y; Xu J; Wang L; Zou L; Cai Y
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32443711
[No Abstract] [Full Text] [Related]
4. Main Risk Factors Association with Proto-Oncogene Mutations in Colorectal Cancer.
Dolatkhah R; Somi MH; Shabanloei R; Farassati F; Fakhari A; Dastgiri S
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2183-2190. PubMed ID: 30139223
[TBL] [Abstract][Full Text] [Related]
5. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
6. MiR-543 inhibits proliferation and metastasis of human colorectal cancer cells by targeting PLAS3.
Su DW; Li X; Chen J; Dou J; Fang GE; Luo CJ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8812-8821. PubMed ID: 32964969
[TBL] [Abstract][Full Text] [Related]
7. The role of PIAS3, p-STAT3 and ALR in colorectal cancer: new translational molecular features for an old disease.
Polimeno L; Francavilla A; Piscitelli D; Fiore MG; Polimeno R; Topi S; Haxhirexha K; Ballini A; Daniele A; Santacroce L
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10496-10511. PubMed ID: 33155205
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
[TBL] [Abstract][Full Text] [Related]
10. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
11. Association of sedentary behavior with the expression levels of biomarkers in colorectal cancer: clinical analysis of 228 patients.
Yu T; Lu Q; Ou X; Cao D; Yu Q
Tohoku J Exp Med; 2014 Mar; 232(3):167-76. PubMed ID: 24621823
[TBL] [Abstract][Full Text] [Related]
12. The unique DEK oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
